Exelixis
EXEL
#1619
Rank
โ‚ฌ11.76 B
Marketcap
46,79ย โ‚ฌ
Share price
0.68%
Change (1 day)
25.59%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company